| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Lava Therapeutics N.V.
13D/A
Amendment 3
LVTX · N51517105
|
3.9% |
10/22/2025
Event 10/20/2025
|
|||
| Cooperatieve Gilde Healthcare IV U.A. | 3.9% | ||||
| Gilde Healthcare IV Management B.V. | 3.9% | ||||
| Gilde Healthcare Holding B.V. | 3.9% | ||||
| Manapouri B.V. | 3.9% | ||||
| Martemanshurk B.V. | 3.9% | ||||
|
Lava Therapeutics N.V.
13D/A
Amendment 2
LVTX · N51517105
|
11.2% |
10/17/2025
Event 10/15/2025
|
|||
| Cooperatieve Gilde Healthcare IV U.A. | 11.2% | ||||
| Gilde Healthcare IV Management B.V. | 11.2% | ||||
| Gilde Healthcare Holding B.V. | 11.2% | ||||
| Manapouri B.V. | 11.2% | ||||
| Martemanshurk B.V. | 11.2% | ||||
|
Lava Therapeutics N.V.
13D/A
Amendment 1
LVTX · N51517105
|
19.9% |
10/14/2025
Event 10/9/2025
|
|||
| Cooperatieve Gilde Healthcare IV U.A. | 19.9% | ||||
| Gilde Healthcare IV Management B.V. | 19.9% | ||||
| Gilde Healthcare Holding B.V. | 19.9% | ||||
| Manapouri B.V. | 19.9% | ||||
| Martemanshurk B.V. | 19.9% | ||||
|
CVRx, Inc.
13D/A
Amendment 3
CVRX · 126638105
|
4.9% |
2/6/2025
Event 2/4/2025
|
|||
| Cooperatieve Gilde Healthcare IV U.A. | 4.9% | ||||
| Gilde Healthcare IV Management B.V. | 4.9% | ||||
| Gilde Healthcare Holding B.V. | 4.9% | ||||
| Manapouri B.V. | 4.9% | ||||
| Martemanshurk B.V. | 4.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.